LC compared Her-Vaxx to Herceptin. Consider the following:
Her-Vaxx safety profile is far better than Herceptin.
Her-Vaxx efficaciy profile is as good, if not better than Herceptin.
Herceptin brings in $7-8bn last year.
Our market cap only about $500m.
Can everyone see how UNDERVALUED IMU is as a whole compared to just Herceptin alone?! We have not even begun with the other pipelines. That means right now, all our pipeline, including this Her-Vaxx which is better than Herceptin in all manner is worth only $500m compared to the revenue of $7-8bn of Herceptin. Let that sink in.
In fact, from these points above, any takeover deal will have to be multiples of $7bn at the very least, just taking Her-Vaxx into account. Then you add the potential values of all the other stuff IMU have. Really, today's share price is not just a present. It can set up a person's future for good if one invest wisely here.
Media Thread, page-148
-
- There are more pages in this discussion • 14,144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1882949 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 399643 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |